Form 4: Arteris Director Sells Shares Under 10b5-1 Plan

Director Saiyed Atiq Raza of Arteris, Inc. has reported the sale of common stock valued at approximately $2.39 million through a pre-arranged trading plan.

Summary

• Director Saiyed Atiq Raza reported transactions involving Arteris, Inc. common stock on June 1, 2026.
• A total of 66,400 shares were sold at a weighted average price of $35.9922, totaling approximately $2,388,855.08.
• An additional 3,600 shares were sold at a weighted average price of $36.4503, totaling approximately $131,221.08.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on November 7, 2025.
• Following these sales, the reporting person beneficially owns 20,839 shares of common stock directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the significant sale of shares by a director, despite being executed under a 10b5-1 plan.

Negatives

• Director Saiyed Atiq Raza sold a significant number of shares (70,000 total) from his holdings.
• The sales represent a reduction in direct and indirect beneficial ownership by a company director.

Risks

• The sale of shares by a director, even under a 10b5-1 plan, could be interpreted negatively by the market, potentially impacting investor sentiment.
• While the plan was adopted in November 2025, the execution in June 2026 might coincide with other market factors affecting the stock price.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing, which solely reports on past transactions.

Industry Context

StockSavvy.ai notes that insider selling, even under a pre-arranged 10b5-1 plan, is a common event for executives and directors. However, the scale of the sale by a director can sometimes be a signal that investors monitor closely, especially if it deviates from typical patterns or occurs during periods of market volatility.

Stakeholder Impact

• Shareholders may view the director's sale as a potential negative signal, possibly leading to short-term price pressure.
• Employees holding stock options or grants may be concerned about the director's reduced confidence in future stock appreciation, although the 10b5-1 plan mitigates this concern to some extent.

Next Steps

• Monitor future filings for any additional transactions by Director Raza or other insiders.
• Observe the market's reaction to these sales and any subsequent share price movements.

Key Dates

Recommendation

The filing reports a sale of shares by a director under a pre-established 10b5-1 plan. While insider selling can be a negative signal, the use of a 10b5-1 plan indicates the sale was pre-planned and not necessarily based on current non-public information. Without other significant negative or positive news in the filing, a 'hold' recommendation is appropriate, suggesting investors maintain their current position while monitoring further developments.

Keywords

Arteris Inc, Form 4, Insider Trading, Director Sale, 10b5-1 Plan, Common Stock, SEC Filing, Saiyed Atiq Raza